Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
The role of the 21-gene assay in the neoadjuvant setting for hormone receptor-positive HER2-negative breast cancer: Impact on systemic and surgical treatment decisions
AuthorsÁ.Guerrero Zotano; T.M. Allweis; R. Foerster; C. Palmieri; O. Gluz; S. Chia; C. Sotiriou; G. Bianchini
AffiliationsMedical Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Dept. of Breast Surgery, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University, Jerusalem, Israel; Exact Sciences (Abbott Cancer Diagnostics), Baar, Zug, Switzerland; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; University of Liverpool, Liverpool, UK; West German Study Group (WSG), Moenchengladbach, Germany; Breast Center Niederrhein, Ev. Hospital Bethesda, Moenchengladbach, Germany; University Clinics Cologne, Women’s Clinic and Breast Center, Cologne, Germany; Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada; Breast Cancer Translational Research Laboratory, Department of Medical Oncology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium; Université Libre de Bruxelles (ULB), Brussels, Belgium; Medical Oncology Department, IRCCS San Raffaele Hospital, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy
Prognostic role of postoperative circulating tumor DNA in metastatic colorectal cancer treated with curative intent: A systematic review and meta-analysis
AuthorsClaudia Cardone; Sergio Facchini; Bruna de Oliveira Ascef; Antonino Cassata; Alfonso De Stefano; Paolo Chiodini; Antonio Avallone
AffiliationsExperimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori- IRCCS-Fondazione G. Pascale, Naples, Italy; Department of Mental and Physical Health and Preventive Medicine. Medical Statistics Unit. Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy
Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposal
AuthorsAldo Caltavituro; Roberto Buonaiuto; Alessandra Longobardi; Paola Trasacco; Claudia Martinelli; Giuseppe Di Grazia; Roberto Pacelli; Grazia Arpino; Carmine De Angelis; Roberta Caputo; Michelino De Laurentiis; Elena Laakmann; Leonor Vasconcelos de Matos; Mário Fontes-Sousa; Mette van Ramshorst; Volkmar Mueller; Elisa Agostinetto; Sabine Linn; Michelangelo De Angelis; Francesco Schettini; Mario Giuliano
AffiliationsOncology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy; Clinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, Napoli, Italy; Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy; University Medical Center Hamburg-Eppendorf, Department of Gynecology, Hamburg, Germany; Breast Cancer Unit, Champalimaud Clinical Centre, Champalimaud Foundation, Lisbon, Portugal; Oncology Unit, Hospital CUF Tejo, Lisbon, Portugal, Oncology Unit, Unidade Local de Saúde Lisboa Ocidental, Lisbon, Portugal; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Gynecology, University Medical Center Hamburg 20246 Hamburg, Germany; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands; IRCCS Istituto Neurologico Mediterraneo Neuromed, Division of Neurosurgery, Isernia, Italy; Clinic Barcelona Comprehensive Cancer Center, Hospital Clinic of Barcelona, Barcelona, Spain; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain
KRAS G12C-mutant non-small cell lung cancer: A practical guide for clinicians
AuthorsJordi Remon; Giulia La-Cava; Maxime Borgeaud; Stephanie P.L. Saw; Lizza EL Hendriks; Biagio Ricciuti
AffiliationsDepartment of Medical Oncology, Thoracic Group, Gustave Roussy, Villejuif, France; Paris-Saclay University, Paris, France; Department of Medicine and Surgery, University Campus Bio-Medico of Rome, Rome, Italy; Oncology Department, University Hospital Geneva, Geneva, Switzerland; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Department of Pulmonary Diseases, Maastricht University Medical Centre (+), GROW Research Institute for Oncology and Reproduction, Maastricht, the Netherlands; Lowe Center of Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States
Circulating tumor DNA for predicting recurrence and mortality in patients with resected Melanoma: A systematic review and meta-analysis
AuthorsPedro C. Abrahão Reis; Mariana Macambira Noronha; João Pedro Oliveira; João Evangelista Ponte Conrado; Isabella Romagnoli Buonopane; Carlos Diego Holanda Lopes; Daniel V. Araujo; Erick F. Saldanha
AffiliationsUniversidade Federal do Rio de Janeiro (UFRJ), RJ, Brazil; Universidade Federal do Ceará (UFC), CE, Brazil; Universidade Federal da Bahia (UFBA), BA, Brazil; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, ON, Canada; Department of Medicine, University of Toronto, ON, Canada; University of Florida, Gainesville, FL, USA; Harvard T. H. Chan School of Public Health, Harvard University, MA, USA
Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors
AuthorsIrene Hernández de Córdoba Sánchez; Mercedes Avedillo Ruidiaz; Victor Moreno; Henry Long; Paloma Cejas
AffiliationsDepartment of Medical Oncology, University Hospital Infanta Sofía, San Sebastián de los Reyes, 28702 Madrid, Spain; Department of Medical Oncology, University Hospital Fundación Jiménez Díaz, Moncloa-Aravaca, 28040 Madrid, Spain; START Madrid-FJD Early Phase Clinical Trials Unit, University Hospital Fundación Jiménez Díaz, 28040 Madrid, Spain; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA
Progress toward personalized management of stage II/III triple negative breast cancer
AuthorsIrene Valle; Joana M Ribeiro; Thomas Grinda; Marleen Kok; Barbara Pistilli; Gustavo Werutsky; Elie Rassy
AffiliationsDepartment of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France; Oncology Unit, AOUC - Careggi University Hospital, University of Florence, Florence, Italy; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; INSERM 1279, Gustave Roussy, Villejuif, France; Hospital São Lucas PUCRS, Porto Alegre, Brazil
Management of infections in the outpatient care of patients with cancer
AuthorsMichael Sandherr; Georg Maschmeyer; Christina Rieger
AffiliationsGerman Society of Hematology and Medical Oncology, Bauhofstr. 12, 10117 Berlin, Germany; German Society of Hematology and Medical Oncology and Charité University, Medicine Bauhofstr. 12, 10117 Berlin, Germany; Hematology Oncology Germering, Landsberger Str.27, 82110 Germering, Germany
Expanding the therapeutic Frontier: Liver transplantation for unresectable colorectal liver metastases
AuthorsAlex B. Munster; Umair Mahmood; Heather Fuller; Hajun Seo; Jamie Murphy; Krishna Menon; Charles Imber; Chetan Bhan; Khurum Khan
AffiliationsDepartment of Cancer Services, Whittington Health NHS Trust, London, UK; Department of Gastrointestinal Oncology, University College London Hospitals NHS Foundation Trust, London, UK; University College London Medical School, London, UK; Cleveland Clinic London, London, UK; Department of General Surgery, University College London Hospitals NHS Foundation Trust, London, UK; Department of Oncology, University College London Cancer Institute, London, UK; The London Clinic in collaboration with Northwestern Medicine, UK
Neoantigen-based dendritic cell vaccines in lung cancer: overcoming immunosuppressive barriers for durable antitumor immunity
AuthorsZhang Li; Zhang Feiyue; Huang Luyu; Zhang Wenqiang; Mahmoud Ismail; Jens-C Rueckert
AffiliationsDepartment of Surgery, Competence Center of Thoracic Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Department of Thoracic Surgery, Klinikum Ernst von Bergmann Potsdam, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany; Department of Oncology, the Sixth Affiliated Hospital of Kunming Medical University, Yuxi, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
